fromArs Technica1 week agoMedicineWhat's the deal with Alzheimer's disease and amyloid?Recent retractions of studies on amyloid-β challenge its role in Alzheimer's disease and highlight failures in drug efficacy targeting this protein.
fromNature1 year agoArtificial intelligenceThe future of Alzheimer's treatmentRecent approvals of anti-amyloid drugs provide hope in Alzheimer's treatment, although their modest effectiveness remains a topic of debate.
MedicinefromArs Technica1 week agoWhat's the deal with Alzheimer's disease and amyloid?Recent retractions of studies on amyloid-β challenge its role in Alzheimer's disease and highlight failures in drug efficacy targeting this protein.
Artificial intelligencefromNature1 year agoThe future of Alzheimer's treatmentRecent approvals of anti-amyloid drugs provide hope in Alzheimer's treatment, although their modest effectiveness remains a topic of debate.